INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 54 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $344,000 | – | 21,281 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMS Capital Management | 391,149 | $1,056,000 | 1.00% |
| ELEMENT CAPITAL MANAGEMENT LLC | 136,192 | $368,000 | 0.08% |
| WELCH & FORBES LLC | 400,614 | $1,081,000 | 0.03% |
| Indiana Trust & Investment Management CO | 19,250 | $52,000 | 0.03% |
| FLAGSHIP HARBOR ADVISORS, LLC | 15,415 | $34,000 | 0.01% |
| LMR Partners LLP | 58,775 | $159,000 | 0.01% |
| BOSTON FINANCIAL MANGEMENT LLC | 49,175 | $133,000 | 0.01% |
| HYMAN CHARLES D | 30,000 | $81,000 | 0.01% |
| Baker Brothers Advisors | 400,000 | $1,080,000 | 0.01% |
| OneDigital Investment Advisors LLC | 8,911 | $24,000 | 0.01% |